For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
All eyes on Dr Bloomfield
Wednesday 15 August 2018, 03:00 AM

Ashley Bloomfield says leadership at the Ministry of Health is not about command and control, but convene and collaborate
Incorrect figures appeared in the 2017 Budget documents, disputes between staff and Canterbury DHB were aired publicly, and a DHB chief executive’s personal spending of public funds went undetected. Can the Ministry of Health recover from recent lows? Virginia McMillan meets the new boss
Rumour and dismay have been rife in recent years when health professionals talked about the Ministry of Health. Recurring themes were low morale, la
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.